Zydus Lifesciences Share Price in Focus; Board Approves Buyback of Up to 95.65 Lakh Equity Shares at ₹1,150 Per Share

Zydus Lifesciences share price is expected to remain in focus after the company disclosed that members of its promoter group and persons in control have conveyed their intention to participate in the recently approved share buyback programme. 

The update follows the board’s approval of a buyback proposal worth up to ₹1,100 crore through the tender offer route.  

Promoters To Participate In ₹1,100 Crore Buyback 

According to the company’s regulatory filing, promoter group entities and persons in control have submitted communications dated May 19, 2026, expressing their intention to tender shares in the proposed buyback, subject to applicable regulations.  

The company had earlier approved the repurchase of up to 95.65 lakh (95,65,217) equity shares at a buyback price of ₹1,150 per share. The buyback represents up to 0.95% of the company’s paid-up equity share capital and will be conducted through the tender offer mechanism.  

Under SEBI’s buyback regulations, promoters are permitted to participate in buybacks executed through the tender offer route. The promoter group may tender shares up to its existing shareholding or a lower quantity as permitted under applicable laws.  

Buyback Seen as Capital Allocation Initiative 

Share buybacks are often undertaken by companies to return surplus cash to shareholders, improve capital efficiency, and potentially enhance shareholder value.  

Participation by promoters generally indicates their willingness to take part in the process under the same terms available to other eligible shareholders. 

Investors are expected to monitor further announcements regarding the buyback timetable, record date, entitlement details, and other procedural aspects associated with the tender offer. 

Read More: Zydus Lifesciences Share Price Gains Over 5% After Q4 FY26 Earnings Results: Net Profit up 8.7% YoY! 

Zydus Lifesciences Share Price Performance 

As of 19 May 2026, at 3:30 PM, Zydus Lifesciences share price closed at ₹1,018.90 per share, reflecting a surge of 2.80% from the previous closing price. 

Conclusion 

The latest disclosure provides additional clarity on the execution of Zydus Lifesciences’ ₹1,100 crore buyback programme, with promoter participation expected to form part of the overall tender process. 

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.